Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
242 studies found for:    "Parkes Weber syndrome" OR "Vascular Malformations"
Show Display Options
RSS Create an RSS feed from your search for:
"Parkes Weber syndrome" OR "Vascular Malformations"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Cryoablation of Venous Vascular Malformations
Condition: Venous Vascular Malformation
Intervention: Device: Percutaneous Image-guided Cryoablation (FPRPR3508 IceRod® PLUS Needles)
2 Recruiting suPERficial Slow-flow Vascular malFORMations Treated With sirolimUS
Condition: Vascular Malformation
Intervention: Drug: Sirolimus
3 Not yet recruiting the Efficiency of Endoscopic Treatment for Recurrent Small Intestinal Bleeding Due to Gastrointestinal Vascular Malformation
Condition: Gastrointestinal Vascular Malformation
Intervention: Device: balloon assisted enteroscopy
4 Recruiting the Efficiency of Thalidomide for Recurrent Small Intestinal Bleeding Due to Gastrointestinal Vascular Malformation
Condition: Gastrointestinal Vascular Malformation
Interventions: Drug: Thalidomide (100mg);   Drug: Thalidomide (50mg);   Drug: placebo
5 Recruiting Efficacy and Safety of Sirolimus in Vascular Anomalies That Are Refractory to Standard Care
Condition: Vascular Malformations
Intervention: Drug: Sirolimus
6 Recruiting Innovative Approaches to Gauge Progression of Sturge-Weber Syndrome
Condition: Sturge-Weber Syndrome
Intervention:
7 Withdrawn Efficacy Study of Thalidomide in Gastrointestinal Vascular Malformation Related Bleeding
Conditions: Gastrointestinal Hemorrhage;   Vascular Malformation
Interventions: Drug: Thalidomide;   Drug: Placebo
8 Withdrawn Retreatment and Its Efficiency of Thalidomide for Vascular Malformation Patients With Failure of First Course Treatment
Conditions: Gastrointestinal Bleeding of Unknown Origin;   Gastrointestinal Vascular Malformation;   Thalidomide Efficiency
Interventions: Drug: Thalidomide;   Other: Placebo
9 Active, not recruiting Cannabidiol Expanded Access Study in Medically Refractory Sturge-Weber Syndrome
Condition: Sturge-Weber Syndrome
Intervention: Drug: Cannabidiol
10 Withdrawn Adjunctive Everolimus (RAD 001) Therapy for Epilepsy in Children With Sturge-Weber Syndrome (SWS)
Condition: Sturge Weber Syndrome
Intervention: Drug: Everolimus
11 Completed Efficacy and Safety Study of Topical Rapamycin Associated With Pulsed Dye Laser in Patients With Sturge-Weber Syndrome
Condition: Sturge- Weber Syndrome
Intervention: Drug: Drug: Topical Rapamycin
12 Completed Incidence of Ocular Antibodies in Patients With Sturge - Weber Syndrome (SWS)
Condition: Sturge - Weber Syndrome (SWS)
Intervention: Other: blood sample tear drop sample
13 Completed Vascular Malformations and Abnormalities of Growth
Condition: Abnormality
Intervention: Procedure: skin biopsy
14 Completed Estimation of the Placental Volume by 3D Ultrasound at 12, 16 and 22 Weeks : Relation With Growth Factors and D-Dimers
Condition: Placenta Vascular Malformation
Intervention: Other: blood sample
15 Recruiting Treatment of Port-wine Mark in Sturge-Weber Syndrome Using Topical Timolol
Conditions: Sturge Weber Syndrome;   Port-wine Mark
Interventions: Drug: Timolol;   Drug: Preservative free artificial tear gel.
16 Completed Use of the Atkins Diet for Children With Sturge Weber Syndrome
Conditions: Epilepsy;   Sturge Weber Syndrome
Intervention: Dietary Supplement: modified Atkins diet
17 Completed Biomarker Development in Sturge-Weber Syndrome
Condition: Sturge-Weber Syndrome
Intervention:
18 Completed Diagnosis of Hemangiomas and Vascular Malformations
Conditions: Hemangiomas;   Vascular Malformations;   Venular Malformations;   Venous Malformations;   Lymphatic Malformations;   Arteriovenous Malformations
Intervention:
19 Recruiting Bone Health in Patients With Overgrowth
Conditions: Bone Mineral Density;   Vascular Malformations
Intervention:
20 Completed Efficacy and Safety of the Mammalian Target of Rapamycin (mTor Rapamycin) Inhibitor in Vascular Malformations
Condition: Cardiovascular Abnormalities
Intervention: Drug: Sirolimus

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.